COVID-19 pneumothorax in the UK: a prospective observational study using the ISARIC WHO clinical characterisation protocol.
Accepted version
Peer-reviewed
Repository URI
Repository DOI
Change log
Authors
Farrell, James
Smith, Ian
Abstract
Population level data from 131 679 patients show that COVID-19 pneumothorax occurs in 0.97% of admitted patients, especially males and smokers, and is associated with increased mortality https://bit.ly/3oB27ez
Description
Keywords
COVID-19, Humans, Observational Studies as Topic, Pneumothorax, SARS-CoV-2, United Kingdom, World Health Organization
Journal Title
Eur Respir J
Conference Name
Journal ISSN
0903-1936
1399-3003
1399-3003
Volume Title
58
Publisher
European Respiratory Society (ERS)
Publisher DOI
Rights
All rights reserved
Sponsorship
National Institute for Health and Care Research (IS-BRC-1215-20014)
Medical Research Council (G1002610)
MRC (MR/V028669/1)
Medical Research Council (G1002610)
MRC (MR/V028669/1)
This work is supported by grants from: the National Institute for Health Research (NIHR; award CO-CIN-01), the Medical Research Council (MRC; grant MC_PC_19059), and by the NIHR Health Protection Research Unit (HPRU) in Emerging and Zoonotic Infections at University of Liverpool in partnership with Public Health England (PHE), in collaboration with Liverpool School of Tropical Medicine and the University of Oxford (award 200907), NIHR HPRU in Respiratory Infections at Imperial College London with PHE (award 200927), Wellcome Trust and Department for International Development (DID; 215091/Z/18/Z), the Bill and Melinda Gates Foundation (OPP1209135), Liverpool Experimental Cancer Medicine Centre (grant reference C18616/A25153), NIHR Cambridge Biomedical Research Centre (BRC-1215-20014) NIHR Imperial College London Biomedical Research Centre (IS-BRC-1215-20013), EU Platform for European Preparedness Against (Re-)emerging Epidemics (PREPARE; FP7 project 602525), and NIHR Clinical Research Network for providing infrastructure support for this research.